Hetero

COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir

The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.

Jun 21, 2020, 14:38 PM IST

Dr Reddy's to launch Hepatitis C drug in India

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

Mar 23, 2015, 18:52 PM IST

Dr Reddy's to launch Hepatitis C drug in India

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

Mar 23, 2015, 17:50 PM IST

Cipla partners with Hetero to launch biosimilar anaemia drug

Pharma major Cipla on Thursday announced a collaboration with Hetero Drugs to launch a medication under the Actorise brand for treatment of anaemia caused due to chronic kidney disease.

Jun 19, 2014, 13:21 PM IST